Schlumberger NV vs Tempus AI — how do they compare? Schlumberger NV trades at $46.39 (market cap $69.36B), while Tempus AI trades at $49.03 (market cap $8.69B). The key difference: Schlumberger NV is far larger — about 8× Tempus AI's market cap, and Schlumberger NV pays a 2.54% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| SLB | TEM | |
|---|---|---|
Market Cap | $69.36B | $8.69B |
Sector | Energy | Broad Market / Factor |
52-Week High | $58.01 | $103.25 |
52-Week Low | $31.72 | $42.37 |
Enterprise Value | $77.58B | $9.37B |
Dividend Yield | 2.54% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $48.41, down 7.74% in the last 24 hours, reflecting a bearish technical signal. The company reported revenue of $1.27 billion in 2025 but a net loss of $245.03 million, with negative profitability metrics. Recent news highlights growth in AI-driven diagnostics and data services, including FDA approvals and research collaborations. The stock is trading well below the analyst consensus price target of $68.50, with a majority of analysts maintaining a Buy rating.
The outlook for TEM is a mix of high growth potential in healthcare AI and significant financial risk due to persistent losses. Investment opportunity lies in its proprietary data platform and expanding market reach, but risks include execution challenges and cash burn. Wall Street sentiment remains positive on long-term prospects, but investors should weigh the volatility against the company's unproven path to profitability.
Trailing returns across standard periods
Latest headlines on both assets
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →